Showing results (2331-2340 of 2,342) with videos related to

Sort By:
Pageof 235
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
The Lancet. Neurology|December 22, 2017
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association studyRita Guerreiro, Owen A Ross, Celia Kun-Rodrigues, et al.
Neurobiology of Aging|November 19, 2018
A comprehensive screening of copy number variability in dementia with Lewy bodiesCelia Kun-Rodrigues, Tatiana Orme, Susana Carmona, et al.
Neurobiology of Disease|April 7, 2019
Heritability and genetic variance of dementia with Lewy bodiesRita Guerreiro, Valentina Escott-Price, Dena G Hernandez, et al.
JAMA Neurology|March 24, 2020
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical TrialsMerit Cudkowicz, Marianne K Chase, Christopher S Coffey, et al.
The American Journal of Psychiatry|October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve ThemOliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
JAMA Neurology|November 17, 2015
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials, Kevin Michael Biglan, Ira Shoulson, et al.
Pharmacopsychiatry|December 15, 2021
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine LevelsJose de Leon, Georgios Schoretsanitis, Robert L Smith, et al.
Nature|April 9, 2022
Rare coding variants in ten genes confer substantial risk for schizophreniaTarjinder Singh, Timothy Poterba, David Curtis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 24, 2023
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD CohortEva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, et al.
Pageof 235